Abstract
A 24-year-old man was admitted to our hospital with circulatory shock in January 2004. There was a history of having been admitted to a different hospital twice in the previ
. These include reports of increased LTE4 (leukotriene E4) urinary excretion (5) , increased IL-2 receptor positive cells (6) and increased CD8 cells surrounding endothelial cells (7) . Complement levels are usually normal (3) . The role of the monoclonal protein found in the sera of many of the cases remains uncertain, with one report demonstrating in vitro endothelial cell apoptosis on exposure to purified monoclonal protein (9) , whereas another found no effect (8) T a b l e 1 . Ch a r a c t e r i s t i c s o (12, 13) . There was accompanying generalized edema in 37 cases with weight gain reported in 10 cases ranging from 2-29 kg (6, 9, (14) (15) (16) (17) . Some reports described the edema to be non pitting (4, 14) . Accompanying effusions/tissue edema included bilateral pleural effusions (9, 15) , pericardial effusion/tamponade (9, 10, 18, 19) , cerebral edema (20) , epiglottic edema (10) and even macular edema leading to blindness (21) . Compartment syndromes or rhabdomyolysis (reflecting leakage into muscles) occurred in 12 cases, some even requiring fasciotomy (4, 10, 14, 18, (22) (23) (24) (25) (26) . Pulmonary edema was reported in 8 cases, all in the recovery phase after intravenous fluid replenishment (6, 10, 13, 15, 21, 24, 25, 27) . Also reported was biventricular enlargement on echocardiography which regressed as the case improved, possibly reflecting leak into myocardial muscle (13) 
Clinical Features

. Oliguria/anuria or deranged renal function tests were reported in many cases but reports of frank renal failure after resolution of acute episode were few (24). Teelucksingh et al commented on the rarity of acute tubular necrosis or loss of consciousness despite unrecordable blood pressure over several hours. They also described weight gain and the occurrence of pulmonary edema in the recovery phase (3).
Laboratory Features
Hematocrit was recorded to be high in all cases except for one case (14) with the mean (±SD) being 63. 5 (12, 17, 22, (24) (25) (26) and mechanical ventilation in 8 cases (9, 12, 13, 15, 20, 23, 24, 27 (16) , Doubek et al (22) , Sabbadini et al (24) , Kawabe et al (17) . Other agents described to be of benefit include prednisone (2 cases) (14, 28) , verapamil (2 cases) (7, 29) , IVIG (intravenous immunoglobulin) (3 cases) (11, 12) , leukotriene modifiers (two cases) (5, 21) , and plasmapheresis (21) . In two cases who developed multiple myeloma, chemotherapy was reported to be effective (11 (11, 19, 30) . Residual neurological deficit (foot drop) was reported as a consequence of compartment syndromes in one case (23) 
Treatment
Acute stage: The therapy in the acute phase consisted of IV fluids (crystalloids and colloids) in all cases, with most episodes resolved with this therapy. Administration of inotropes was reported in 6 cases
Prognosis
Among the cases analyzed, the median number of episodes was 3 (inter-quartile range 2-7.75), in a median follow-up of 5 years (inter-quartile range 1.5-9). Data on the duration of a single episode is scarcely reported. Thirty-four cases were alive and 14 dead, with no information on the rest. The two series available also reported similar figures. The French series reported 3 deaths out of 11 cases in follow-up (30%) with a mean follow-up of 6.6 years (11). The Mayo clinic series reported 2 deaths out of 8 cases (25%) with a median follow up of 9 years (10). Progression to multiple myeloma has been reported in 4 cases
